| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Hydromedix To Raise $250k
Posted on 11/02/2007 11:31:26 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
Hydromedix, a West Palm Beach, FL, company that makes devices to accelerate healing, announced yesterday that it will raise about $250,000 to fund prototype development of an appendage apparatus for use with the company’s patented technology, Dry Contact Whirlpool Therapy.
The technology speeds the healing process for post-operative surgical patients and those undergoing radiation therapy, and speeds the rehabilitating process for injured athletes, by applying heat or cold to the injured area.
CEO Brian Meserlian said in a statement that the $250K will allow the firm to complete all phases of prototype design, adding, “We are significantly closer to achieving our goals of getting the prototypes into clinics for testing on patients and are confident once our products are in the market, they will improve the healing process more rapidly than the traditional healing methods.”
Source: OneMedPlace.com
RELATED READING:
- Biotech and Medical Venture Deals Roundup
______________________
Med Tech Sentinel
Hydromedix, a West Palm Beach, FL, company that makes devices to accelerate healing, announced yesterday that it will raise about $250,000 to fund prototype development of an appendage apparatus for use with the company’s patented technology, Dry Contact Whirlpool Therapy.
The technology speeds the healing process for post-operative surgical patients and those undergoing radiation therapy, and speeds the rehabilitating process for injured athletes, by applying heat or cold to the injured area.
CEO Brian Meserlian said in a statement that the $250K will allow the firm to complete all phases of prototype design, adding, “We are significantly closer to achieving our goals of getting the prototypes into clinics for testing on patients and are confident once our products are in the market, they will improve the healing process more rapidly than the traditional healing methods.”
Source: OneMedPlace.com
RELATED READING:
- Biotech and Medical Venture Deals Roundup
______________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Real Estate Marketing Blog
- Morpheus Trading
- Alpha Trends
- Millionaire Now! by Larry Nusbaum
- Random Roger's Big Picture
- Biiwii.com Notes
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
<< My Home | TheMoneyBlogs Home